A start-up enterprise in the U.K. is commercializing research from a university lab that discovered a new class of antibiotics promising to treat drug-resistant bacterial infections. . . . → Read More: Spin-Off Company Developing New Antibiotics
|
|||||
A company in the U.K. developing automated treatments for phobias using immersive virtual reality is raising £3.2 million ($US 5.1 million) in its first venture funding round. . . . → Read More: Virtual Reality Therapy Company Gains $5.1M in Early Funds 
In this weekend’s infographic, we offer a report from the Worldwide Broadband Speed League, a year-long compilation of 163 million Internet speed tests in 200 countries. . . . → Read More: Infographic – Countries with Fastest Internet Speeds 
A new enterprise in the U.K. is developing a wearable heart monitor that diagnoses irregular heart rhythms with artificial intelligence using cloud-based algorithms. . . . → Read More: Univ. Spin-Off Developing A.I.-Boosted Heart Monitor 
A group of entrepreneurs and leading scientists in the U.K. unveiled a venture investment fund that plans to back start-up companies developing a wide range of ground-breaking technologies. . . . → Read More: Scientists, Investors Form $100M+ Tech Venture Fund  Comments are closed  Finance  biomedical, engineering, entrepreneurs, equity, Europe, investment, life sciences, physical sciences, physics, U.K., university, venture capital 
A developer of synthetic antibodies that invoke the immune system is partnering with the biopharmaceutical company Genentech to design new therapies for blood-related and solid tumor cancers. . . . → Read More: Genentech Gains Modular Engineered Antibodies in $5B Deal Comments are closed Joint ventures/collaborations biomedical, biotechnology, cancer, Europe, licensing, life sciences, pharmaceuticals 
Researchers in France developed a system for computing data from CT scans and genomic analysis to predict the success for therapies that invoke the immune system in patients with solid-tumor cancers. . . . → Read More: A.I., Imaging Shown to Predict Immunotherapy Success 3 comments - (Comments are closed) New products biomedical, cancer, clinical trials, engineering, entrepreneurs, Europe, genomics, life sciences, mathematics, medical device, pharmaceuticals, physical sciences, university 
Two recent studies describe methods for fabricating the material graphene into complex shapes with 3-D printing, as well as showing graphene can likely degrade inside the human body. . . . → Read More: Graphene Extended for 3-D Printing, Medical Devices Comments are closed New products biomedical, chemistry, engineering, Europe, life sciences, materials science, medical device, physical sciences, university 
Researchers in Italy and the U.S. found a potential source of new antibiotics in derivatives of peptides used by the digestive process in the stomach. . . . → Read More: New Antibiotics Discovered in Stomach Peptides Comments are closed New products biomedical, biotechnology, engineering, Europe, life sciences, mathematics, pharmaceuticals, physical sciences, preclinical, university 
A biotechnology company in Germany and drug maker Pfizer are developing a vaccine to prevent seasonal influenza using messenger RNA that instructs cells on production of proteins. . . . → Read More: Pfizer, Biotech Partner on RNA Flu Vaccine 2 comments - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, equity, Europe, investment, licensing, life sciences, pharmaceuticals |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
